Neurotransmitter receptors play a key role in most research on antipsychotic drugs, but little is known about the effects of these drugs on the plasma membrane in the central nervous system. Therefore, we investigated whether chlorpromazine (CPZ), a typical phenothiazine antipsychotic drug, affects the plasma membrane integrity in the rat brain, and if so, whether these membrane alterations can be prevented by dietary supplementation with vitamin E, which has been shown to be an antioxidant and also a membrane-stabilizer. Leakage of [18F]2-fluoro-2-deoxy-D-glucose ([18F]FDG)-6-phosphate from rat striatal slices and decrease in 1,6-diphenyl-1,3,5-hexatriene fluorescence anisotropy were used as indexes for plasma membrane permeabilization and fluidization, respectively. CPZ induced leakage of [18F]FDG-6-phosphate from striatal slices, and the leakage was delayed in the vitamin E-supplemented group compared to that in the normal diet group. The decrease in plasma membrane anisotropy induced by CPZ was significantly attenuated by vitamin E supplementation. Chronic treatment with α-phenyl-N-tert-butyl nitrone, a free radical scavenger, had no effect on CPZ-induced plasma membrane permeabilization, and the treatment with CPZ did not induce lipid peroxidation. CPZ can reduce plasma membrane integrity in the brain, and this reduction can be prevented by vitamin E via its membrane-stabilizing properties, not via its antioxidant activity.
Adler L.A., Edson R., Lavori P., Peselow E., Duncan E., Rosenthal M., Rotrosen J. (1998) Long-term treatment effects of vitamin E for tardive dyskinesia. Biol Psychiatry43: 868—872
2.
Adler L.A., Peselow E., Rotrosen J., Duncan E., Lee M., Rosenthal M., Angrist B. (1993) Vitamin E treatment of tardive dyskinesia. Am J Psychiatry150: 1405—1407
3.
Andreoli S.P., Baehner R.L., Bergstein J.M. (1985) In vitro detection of endothelial cell damage using 2-deoxy-D-3H-glucose: comparison with chromium 51, 3H-leucine, 3H-adenine, and lactate dehydrogenase. J Lab Clin Med106: 253—261
4.
Ashwell J.D., Schwartz R.H., Mitchell J.B., Russo A. (1986) Effect of gamma radiation on resting B lymphocytes. I. Oxygen-dependent damage to the plasma membrane results in increased permeability and cell enlargement. J Immunol136: 3649—3656
Balijepalli S., Boyd M.R., Ravindranath V. (1999) Inhibition of mitochondrial complex I by haloperidol: the role of thiol oxidation. Neuropharmacology38: 567—577
7.
Bartels M., Themelis J. (1983) Computerized tomography in tardive dyskinesia. Evidence of structural abnormalities in the basal ganglia system. Arch Psychiatr Nervenkr233: 371—379
8.
Behl C., Rupprecht R., Skutella T., Holsboer F. (1995) Haloperidol-induced cell death—mechanism and protection with vitamin E in vitro Neuroreport 7: 360—364
9.
Brown K.W., Wardlaw J.M., White T., Walker N. (1996) Caudate nucleus area in drug-induced parkinsonism . Acta Psychiatr Scand94: 348—351
10.
Burkhardt C., Kelly J.P., Lim Y.H., Filley C.M., Parker W.D. Jr (1993) Neuroleptic medications inhibit complex I of the electron transport chain. Ann Neurol33: 512—517
11.
Carney J.M., Floyd R.A. (1991) Protection against oxidative damage to CNS by α-phenyl-tert-butyl nitrone (PBN) and other spin-trapping agents: a novel series of nonlipid free radical scavengers. J Mol Neurosci3: 47—57
12.
Carney J.M., Starke-Reed P.E., Oliver C.N., Landum R.W., Cheng M.S., Wu J.F., Floyd R.A. (1991) Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-α-phenylnitrone . Proc Natl Acad Sci USA88: 3633—3636
13.
Chen S., Gjerde A.U., Holmsen H., Nerdal W. (2005) Importance of polyunsaturated acyl chains in chlorpromazine interaction with phosphatidylserines: a 13C and 31P solid-state NMR study . Biophys Chem117: 101—109
14.
Conley R.R., Kelly D.L. (2005) Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects. Isr J Psychiatry Relat Sci42: 51—60
15.
Coombes J.S., Powers S.K., Demirel H.A., Jessup J., Vincent H.K., Hamilton K.L., Naito H., Shanely R.A., Sen C.K., Packer L., Ji L.L. (2000) Effect of combined supplementation with vitamin E and alpha-lipoic acid on myocardial performance during in vivo ischaemia-reperfusion . Acta Physiol Scand169: 261—269
16.
Diplock A.T., Lucy J.A. (1973) The biochemical modes of action of vitamin E and selenium: A hypothesis. FEBS Lett29: 205—210
17.
Dwyer D.S., Lu X.H., Bradley R.J. (2003) Cytotoxicity of conventional and atypical antipsychotic drugs in relation to glucose metabolism. Brain Res971: 31—39
18.
Egan M.F., Apud J., Wyatt R.J. (1997) Treatment of tardive dyskinesia. Schizophr Bull123: 583—609
19.
Egan M.F., Hyde T.M., Albers G.W., Elkashef A., Alexander R.C., Reeve A., Blum A., Saenz R.E., Wyatt R.J. (1992) Treatment of tardive dyskinesia with vitamin E . Am J Psychiatry149: 773—777
20.
Elkashef A.M., Ruskin P.E., Bacher N., Barrett D. (1990) Vitamin E in the treatment of tardive dyskinesia . Am J Psychiatry147: 505—506
21.
Fukuzawa K., Chida H., Suzuki A. (1980) Fluorescence depolarization studies of phase transition and fluidity in lecithin liposomes containing αtocopherol. J Nutr Sci Vitaminol26: 427—434
22.
Fukuzawa K., Hayashi K., Suzuki A. (1977) Effects of α-tocopherol analogs on lysosome membranes and fatty acid monolayers. Chem Phys Lipids18: 39—48
23.
Fukuzawa K., Ikeno H., Tokumura A., Tsukatani H. (1979) Effect of α-tocopherol incorporation of glucose permeability and phase transition of lecithin liposomes. Chem Phys Lipids23: 13—21
24.
Galili-Mosberg R., Gil-Ad I., Weizman A., Weizman A., Melamed E., Offen D. (2000) Haloperidol-induced neurotoxicity — possible implications for tardive dyskinesia. J Neural Transm107: 479—490
Goldstein D.B. (1984) The effects of drugs on membrane fluidity. Annu Rev Pharmacol Toxicol24: 43—64
27.
Gray E.G., Whittaker V.P. (1962) The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J Anat96: 79—88
28.
Grohmann R., Koch R., Schmidt L.G. (1990) Extrapyramidal symptoms in neuroleptic recipients . Agents Actions Suppl29: 71—82
29.
Hägerstrand H., Danieluk M., Bobrowska-Hägerstrand M., Igliç A., Wróbel A., Isomaa B., Nikinmaa M. (2000) Influence of band 3 protein absence and skeletal structures on amphiphile- and Ca2+-induced shape alterations in erythrocytes: a study with lamprey (Lampetra fluviatilis), trout (Onchorhynchus mykiss) and human erythrocytes. Biochim Biophys Acta1466: 125—138
30.
Hamacher K., Coenen H.H., Stocklin G. (1986) Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med27: 235—238
31.
Haramaki N., Assadnazari H., Zimmer G., Schepkin V., Packer L. (1995) The influence of vitamin E and dihydrolipoic acid on cardiac energy and glutathione status under hypoxia-reoxygenation. Biochem Mol Biol Int37: 591—597
32.
Haramaki N., Packer L., Assadnazari H., Zimmer G. (1993) Cardiac recovery during post-ischemic reperfusion is improved by combination of vitamin E with dihydrolipoic acid. Biochem Biophys Res Commun196: 1101—1107
33.
Holmsen H., Rygh T. ( 1990) Chlorpromazine makes the platelet plasma membrane permeable for low-molecular weight substances and reduces ATP production. Biochem Pharmacol40: 373—376
34.
Huang J., Tanii H., Ohyashiki T., Hashimoto K. (1993) Structure-toxicity relationship of monoketones: in vitro effects on beta-adrenergic receptor binding and Na+/K+-ATPase activity in mouse synaptosomes. Neurotoxicol Teratol15: 345—352
35.
Hueck I.S., Hollweg H.G., Schmid-Schonbein G.W., Artmann G.M. (2000) Chlorpromazine modulates the morphological macro- and microstructure of endothelial cells. Am J Physiol Cell Physiol278: C873
36.
Janero D.R. (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury . Free Radic Biol Med9: 515—540
37.
Jeste D.V., Caligiuri M.P. (1993) Tardive dyskinesia. Schizophr Bull19: 303—315
38.
Katsu T., Kobayashi H., Hirota T., Fujita Y., Sato K., Nagai U. (1987) Structureactivity relationship of gramicidin S analogues on membrane permeability. Biochim Biophys Acta899: 159—170
39.
Katsu T., Kuroko M., Morikawa T., Sanchika K., Fujita Y., Yamamura H., Uda M. (1989) Mechanism of membrane damage induced by the amphipathic peptides gramicidin S and melittin. Biochim Biophys Acta983: 135—141
40.
Katsu T., Kuroko M., Morikawa T., Sanchika K., Yamanaka H., Shinoda S., Fujita Y. (1990) Interaction of wasp venom mastoparan with biomembranes . Biochim Biophys Acta1027: 185—190
41.
Katsu T., Nakao S., Iwanaga S. (1993) Mode of action of an antimicrobial peptide, tachyplesin I, on biomembranes. Biol Pharm Bull16: 178—181
42.
Klawans H.L., Goetz C.G., Perlik S. (1980) Tardive dyskinesia: review and update. Am J Psychiatry137: 900—908
43.
Kristensen S.R., Horder M. (1988) Release of enzymes from quiescent fibroblasts during ATP depletion. Enzyme39: 205—212
44.
Lieberman J.A. (2004) Dopamine partial agonists: a new class of antipsychotic . CNS Drugs18: 251—267
45.
Lohr J.B., Cadet J.L., Lohr M.A., Larson L., Wasli E., Wade L., Hylton R., Vidoni C., Jeste D.V., Wyatt R.J. (1988) Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms. Schizophr Bull14: 291—296
46.
Lohr J.B., Caligiuri M.P. (1996) A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. J Clin Psychiatry57: 167—173
47.
Machlin L.J., Gabriel E. (1982) Kinetics of tissue α-tocopherol uptake and depletion following administration of high levels of vitamin E. Ann NY Acad Sci393: 48—60
48.
Malik J.K., Schwarz L.R., Wiebel F.J. (1983) Assessment of membrane damage in continuous cultures of mammalian cells. Chem Biol Interact45: 29—42
49.
Margolese H.C., Chouinard G., Kolivakis T.T., Beauclair L., Miller R. (2005) Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction. Can J Psychiatry50: 541—547
50.
Marsden C.D., Jenner P. (1980) The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med10: 55—72
51.
Maurer I., Möller H.J. (1997) Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics. Mol Cell Biochem174: 255—259
52.
Miller R., Chouinard G. (1993) Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced super-sensitivity psychosis and refractory schizophrenia. Biol Psychiatry34: 713—738
53.
Mion C.C., Andreasen N.C., Arndt S., Swayze II V W, Cohen G.A. (1991) MRI abnormalities in tardive dyskinesia. Psychiatry Res40: 157—166
54.
Murata T., Omata N., Fujibayashi Y., Waki A., Sadato N., Yoshida S., Yano R., Yoshimoto M., Yonekura Y. (1999) Dynamic changes in glucose metabolism of living rat brain slices induced by hypoxia and neurotoxic chemical-loading revealed by positron autoradiography. J Neural Transm106: 1075—1087
55.
Niki E. ( 1987) Antioxidants in relation to lipid peroxidation. Chem Phys Lipids44: 227—253
56.
Noji S., Takahashi T., Kon H. (1982) A spin-label study of the correlation between stomatocyte formation and membrane fluidization of erythrocytes. Biochem Pharmacol31: 3173—3180
57.
Ohyashiki T., Sakata N., Matsui K. (1992) A decrease of lipid fluidity of the porcine intestinal brush-border membranes by treatment with malondialdehyde. J Biochem111: 419—423
58.
Omata N., Murata T., Fujibayashi Y., Waki A., Sadato N., Yoshimoto M., Wada Y., Yonekura Y. (2000) Hypoxic but not ischemic neurotoxicity of free radicals revealed by dynamic changes in glucose metabolism of fresh rat brain slices on positron autoradiography. J Cereb Blood Flow Metab20: 350—358
59.
Pai B.N., Janakiramaiah N., Gangadhar B.N., Ravindranath V. (1994) Depletion of glutathione and enhanced lipid peroxidation in the CSF of acute psychotics following haloperidol administration. Biol Psychiatry36: 489—491
60.
Post A., Holsboer F., Behl C. ( 1998) Induction of NF-κB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-κB and neuroprotection by antioxidants. J Neurosci18: 8236—8246
61.
Rajput A.H., Rozdilsky B., Hornykiewicz O., Shannak K., Lee T., Seeman P. (1982) Reversible drug-induced parkinsonism. Clinicopathological study of two cases. Arch Neurol39: 644—646
62.
Rissanen E., Krumschnabel G., Nikinmaa M. (2003) Dehydroabietic acid, a major component of wood industry effluents, interferes with cellular energetics in rainbow trout hepatocytes . Aquat Toxicol62: 45—53
63.
Sack C.A., Socci D.J., Crandall B.M., Arendash G.W. (1996) Antioxidant treatment with phenyl-α-tert-butyl nitrone (PBN) improves the cognitive performance and survival of aging rats . Neurosci Lett205: 181—184
64.
Sagara Y. (1998) Induction of reactive oxygen species in neurons by haloperidol. J Neurochem71: 1002—1012
65.
Scuntaro I., Kientsch U., Wiesmann U.N., Honegger U.E. (1996) Inhibition by vitamin E of drug accumulation and of phospholipidosis induced by desipramine and other cationic amphiphilic drugs in human cultured cells. Br J Pharmacol119: 829—834
66.
Seeman P., Staiman A., Lee T., Chau-Wong M. (1974) The membrane actions of tranquilizers in relation to neuroleptic-induced parkinsonism and tardive dyskinesia. Adv Biochem Psychopharmacol9: 137—148
67.
Sergent O., Pereira M., Belhomme C., Chevanne M., Huc L., Lagadic-Gossmann D. (2005) Role for membrane fluidity in ethanol-induced oxidative stress of primary rat hepatocytes. J Pharmacol Exp Ther313: 104—111
68.
Sheetz M.P., Singer S.J. (1974) Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc Natl Acad Sci USA71: 4457—4461
69.
Shinitzky M., Barenholz Y. (1978) Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim Biophys Acta515: 367—394
70.
Shinitzky M., Inbar M. (1976) Microviscosity parameters and protein mobility in biological membranes. Biochim Biophys Acta433: 133—149
71.
Shivakumar B.R., Ravindranath V. (1992) Oxidative stress induced by administration of the neuroleptic drug haloperidol is attenuated by higher doses of haloperidol . Brain Res595: 256—262
72.
Shivakumar B.R., Ravindranath V. (1993) Oxidative stress and thiol modification induced by chronic administration of haloperidol. J Pharmacol Exp Ther265: 1137—1141
73.
Silvestri S., Seeman M.V., Negrete J.C., Houle S., Shammi C.M., Remington G.J., Kapur S., Zipursky R.B., Wilson A.A., Christensen B.K., Seeman P. (2000) Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology152: 174—180
74.
Tanii H., Huang J., Ohyashiki T., Hashimoto K. (1994) Physical-chemicalactivity relationship of organic solvents: effects on Na+/K+-ATPase activity and membrane fluidity in mouse synaptosomes. Neurotoxicol Teratol16: 575—582
75.
Tanii H., Zhang X.P., Ohyashiki T. (1995) In vitro influences of alcohols on mouse synaptosomes, and structure-activity relationships. Arch Toxicol69: 617—623
76.
Tharmapathy P., Fukami M.H., Holmsen H. (2000) The stimulatory effects of cationic amphiphilic drugs on human platelets treated with thrombin. Biochem Pharmacol60: 1267—1277
77.
Tsai A.C., Kelley J.J., Peng B., Cook N. ( 1978) Study on the effect of megavitamin E supplementation in man. Am J Clin Nutr31: 831—837
78.
Urano S., Asai Y., Makabe S., Matsuo M., Izumiyama N., Ohtsubo K., Endo T. ( 1997) Oxidative injury of synapse and alteration of antioxidative defense systems in rats, and its prevention by vitamin E. Eur J Biochem245: 64—70
79.
Urano S., Iida M., Otani I. Matsuo M (1987) Membrane stabilization of vitamin E; interactions of α-tocopherol with phospholipids in bilayer liposomes. Biochem Biophys Res Commun146: 1413—1418
80.
Urano S., Yano K., Matsuo M. (1988) Membrane-stabilizing effect of vitamin E: effect of α-tocopherol and its model compounds on fluidity of lecithin liposomes . Biochem Biophys Res Commun150: 469—475
81.
Volles M.J., Lansbury P.T. Jr (2002) Vesicle permeabilization by protofibrillar α-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry41: 4595—4602
82.
Volles M.J., Lee S.J., Rochet J.C., Shtilerman M.D., Ding T.T., Kessler J.C., Lansbury P.T. Jr (2001) Vesicle permeabilization by protofibrillar αsynuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry40: 7812—7819
83.
Waddington J.L. (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology101: 431—447
84.
Walum E., Peterson A. (1982) Tritiated 2-deoxy-D-glucose as a probe for cell membrane permeability studies. Anal Biochem120: 8—11
85.
Yabuki M., Tani N., Yoshioka T., Nishibe H., Kanamaru H., Kaneko H. (2000) Local thrombus formation in the site of intravenous injection of chlorpromazine: possible colloid-osmotic lysis of the local endothelial cells. Biol Pharm Bull23: 957—961
86.
Yokoyama H., Kasai N., Ueda Y., Niwa R., Konaka R., Mori N., Tsuchihashi N., Matsue T., Ohya-Nishiguchi H., Kamada H. (1998) In vivo analysis of hydrogen peroxide and lipid radicals in the striatum of rats under longterm administration of a neuroleptic . Free Radic Biol Med24: 1056—1060
